Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine vs Chloroquine in Acute Non-severe P. Vivax Malaria
NCT02348788Phase 3Unknown
- Sponsor
- Menzies School of Health Research
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artemether + lumefantrine in malaria, sponsored by Menzies School of Health Research. Status: unknown.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02348788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348788.